Ferrochelatase (FECH) Gene Mutation Analysis
Nervous System/Brain Cancer Panel, NGS
21-Hydroxylase Antibody
HLA A Genotype
Clorazepate, Urine
Legionella pneumophila Antibody, IgM by IFA
Pyruvate, Spinal Fluid
Rare Constitutional and hereditary Diseases, Whole Exome Sequence Analysis, NGS
MDM2 Gene Amplification, FISH
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Turnaround Time
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now
Loading...